$87.05
▲ +1.2% Today
as of Sep 4, 16:56 ET
Last 30 days
Recent Press Releases & News
GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates?
Overview
52-week range
$32
$171
40% of range
Avg surprise (last 3)
+62.6%
Avg reaction (last 2)
-19.5%
50% positive
Latest IV / EM
100%
EM ±4.2% · $86 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.60 | — | — | — | — | financials |
| Mon May 4, 2026 | Mar/2026 | $-0.28 | $-0.06 | -366.7% | -200.0% | +3.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.27 | — | — | — | — | financials |
| Tue Jul 29, 2025 | Jun/2025 | $0.50 | $0.10 | +400.0% | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $0.28 | $0.11 | +154.6% | — | -42.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.31 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.10 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.78 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.64 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.84 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-3.04 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $114M | $102M | — | $117M | $103M | $87M | — | $77M |
| Cost of revenue | $36M | $34M | — | $32M | $32M | $29M | — | $29M |
| Gross profit | $78M | $68M | — | $85M | $71M | $58M | — | $48M |
| Operating income | $-17M | $-57M | — | $-3M | $9M | $-5M | — | $-8M |
| Net income | $-18M | $-63M | — | $-8M | $11M | $-7M | — | $-8M |
| EPS (diluted) | $-0.60 | $-2.16 | — | $-0.27 | $0.36 | $-0.23 | — | $-0.31 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $60M | $94M | $105M | $96M | $74M | $100M | $85M | $58M |
| Inventory | $18M | $12M | $14M | $11M | $12M | $13M | $11M | $11M |
| Total current assets | $246M | $271M | $268M | $238M | $205M | $226M | $198M | $186M |
| Total assets | $481M | $506M | $524M | $494M | $464M | $446M | $419M | $409M |
| Long-term debt | $97M | $97M | $48M | $52M | $52M | $52M | $52M | $52M |
| Total liabilities | $237M | $252M | $216M | $202M | $187M | $189M | $174M | $204M |
| Total equity | $244M | $254M | $308M | $292M | $277M | $257M | $245M | $205M |